Drug · DIN 02242470
CORVERT
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since October 3, 2017; first marketed November 28, 2000.
- Drug Identification Number (DIN)
- 02242470
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Ibutilide C01BD05
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| IBUTILIDE FUMARATE | 0.1 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 4, 2016: NOC 18558Supplement to a New Drug Submission (SNDS) · Change the product name from 'corvert injection' to 'corvert'
- September 16, 2003: NOC 1391New Drug Submission (NDS) · Manufacturer name change
- August 15, 2001: NOC 2331New Drug Submission (NDS) · Manufacturer name change
- July 14, 2000: NOC 1221New Drug Submission (NDS)